Population Health
The J&J scientists said that out of 75,000 participants in a clinical trial, there was just one case of cerebral venous sinus thrombosis.
While none are officially FDA approved, the agency has cleared them under emergency use authorization.
Round 2 is a $249.95 million federal initiative that builds on the $200 million program established as part of the CARES Act.
The impact of COVID-19 is felt most severely in communities of color, yet the disparities have not been the result of the pandemic.
Vaccine opposition at a social media event inspired the creation of new guidelines to combat misinformation.
Acquisition to deliver new cloud and AI capabilities across healthcare and other industries.
Intermountain is financing a new university program that will teach practitioners to provide preemptive care.
Officials stress that the reactions fell within the normal range and found "no cause for concern."
This is the second investment for the newly-created Advocate Aurora Enterprises, which was formed to invest to care beyond clinical care settings.
Diagnostic Robotics’ AI efforts are aimed at lowering costs by focusing on targeted interventions, medical adherence and hospitalization prevention.